Advertisement | | CATS RNA-seq for small RNA: new benchmarking study
New paper describes RNA-seq library preparation using “Capture and Amplification by Tailing and Switching” and shows: - Higher small non-coding RNA diversity and greatly reduced hands-on time
- Ligation-free assay - increased efficiency and minimum bias
- Low inputs down to 10 picograms
- Comparison of the CATS method vs. other RNA-seq methods
Learn more and read the new paper. | | | | | |
TABLE OF CONTENTS
| | | | Volume 36, Issue 26 (June 2017) | | In this issue Original Articles Short Communications Corrigendum
Also new AOP | | | | | Advertisement | | | | | Original Articles | Top | | Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia OPENM H A van Attekum, S Terpstra, E Slinger, M von Lindern, P D Moerland, A Jongejan, A P Kater and E Eldering Oncogene 2017 36: 3651-3660; advance online publication, February 13, 2017; 10.1038/onc.2016.515 Abstract | Full Text | | | | Oncogenic signaling by Kit tyrosine kinase occurs selectively on the Golgi apparatus in gastrointestinal stromal tumors OPENY Obata, K Horikawa, T Takahashi, Y Akieda, M Tsujimoto, J A Fletcher, H Esumi, T Nishida and R Abe Oncogene 2017 36: 3661-3672; advance online publication, February 13, 2017; 10.1038/onc.2016.519 Abstract | Full Text | | | | Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization OPENJr-M Yang, P Schiapparelli, H-N Nguyen, A Igarashi, Q Zhang, S Abbadi, L M Amzel, H Sesaki, A Quiñones-Hinojosa and M Iijima Oncogene 2017 36: 3673-3685; advance online publication, March 6, 2017; 10.1038/onc.2016.493 Abstract | Full Text | | | | The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemiaJ Wakim, E Arman, S Becker-Herman, M P Kramer, E Bakos, I Shachar and A Elson Oncogene 2017 36: 3686-3694; advance online publication, February 6, 2017; 10.1038/onc.2016.523 Abstract | Full Text | | | | CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signalingC Lin, W Liao, Y Jian, Y Peng, X Zhang, L Ye, Y Cui, B Wang, X Wu, Z Xiong, S Wu, J Li, X Wang and L Song Oncogene 2017 36: 3695-3705; advance online publication, February 6, 2017; 10.1038/onc.2016.525 Abstract | Full Text | | | | A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial–mesenchymal transition in cancerN V Sankpal, T P Fleming, P K Sharma, H J Wiedner and W E Gillanders Oncogene 2017 36: 3706-3717; advance online publication, February 13, 2017; 10.1038/onc.2016.504 Abstract | Full Text | | | | C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisitionA Cannistraci, G Federici, A Addario, A L Di Pace, L Grassi, G Muto, D Collura, M Signore, L De Salvo, S Sentinelli, G Simone, M Costantini, S Nanni, A Farsetti, V Coppola, R De Maria and D Bonci Oncogene 2017 36: 3718-3728; advance online publication, February 13, 2017; 10.1038/onc.2016.505 Abstract | Full Text | | | | Ras–Erk signaling induces phosphorylation of human TLE1 and downregulates its repressor functionT Zahavi, A Maimon, T Kushnir, R Lange, E Berger, D Kornspan, R Grossman, S Anzi, E Shaulian, R Karni, H Nechushtan and Z Paroush Oncogene 2017 36: 3729-3739; advance online publication, February 13, 2017; 10.1038/onc.2016.517 Abstract | Full Text | | | | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomasZ Liu, K Yanagisawa, S Griesing, M Iwai, K Kano, N Hotta, T Kajino, M Suzuki and T Takahashi Oncogene 2017 36: 3740-3748; advance online publication, February 13, 2017; 10.1038/onc.2016.524 Abstract | Full Text | | | | Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy OPENB A Castro, P Flanigan, A Jahangiri, D Hoffman, W Chen, R Kuang, M De Lay, G Yagnik, J R Wagner, S Mascharak, M Sidorov, S Shrivastav, G Kohanbash, H Okada and M K Aghi Oncogene 2017 36: 3749-3759; advance online publication, February 20, 2017; 10.1038/onc.2017.1 Abstract | Full Text | | | | The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulationY Li, T Zhou, Y Wang, C Ning, Z Lv, G Han, J C Morris, E N Taylor, R Wang, H Xiao, C Hou, Y Ma, B Shen, J Feng, R Guo, Y Li and G Chen Oncogene 2017 36: 3760-3771; advance online publication, February 20, 2017; 10.1038/onc.2017.2 Abstract | Full Text | | | | Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progressionG Y Wang, C N Wood, J A Dolorito, E Libove and E H Epstein, Jr Oncogene 2017 36: 3772-3780; advance online publication, March 6, 2017; 10.1038/onc.2017.12 Abstract | Full Text | | Short Communications | Top | | CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stabilityC Dozier, L Mazzolini, C Cénac, C Froment, O Burlet-Schiltz, A Besson and S Manenti Oncogene 2017 36: 3781-3788; advance online publication, February 13, 2017; 10.1038/onc.2016.506 Abstract | Full Text | | | | Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activationI D Tonks, P Mukhopadhyay, W A Schroder, A Sorolla, A W Mould, H Y Handoko, B Ferguson, H K Muller, P Keith, N K Hayward, G J Walker and G F Kay Oncogene 2017 36: 3789-3795; advance online publication, February 13, 2017; 10.1038/onc.2016.511 Abstract | Full Text | | Corrigendum | Top | | Girdin maintains the stemness of glioblastoma stem cellsA Natsume, T Kato, S Kinjo, A Enomoto, H Toda, S Shimato, F Ohka, K Motomura, Y Kondo, T Miyata, M Takahashi and T Wakabayashi Oncogene 2017 36: 3796; advance online publication, February 20, 2017; 10.1038/onc.2017.17 Full Text | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. | | | | |
No comments:
Post a Comment